Tefferi et al. investigated 179 primary MDS patients that had a higher frequency (30%) of ASXL1 mutation and observed that ASXL1 mutations were less likely to co-exist with SF3B1, U2AF1, and SRSF2 mutations [48]. The gene discussed is SRSF2; the disease is myelodysplastic syndrome.